Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2024-05-17

FDA Approved: FROVATRIPTAN — Supplemental Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

FDA approved a supplemental application for Frovatriptan succinate from Amneal Pharmaceuticals NY LLC. This action updates the product labeling under a suppleme…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • FROVATRIPTAN (FROVATRIPTAN SUCCINATE)

Snippet

SUPPL AP for FROVATRIPTAN (FROVATRIPTAN SUCCINATE)